# Low-Dose Ketamine in Children With ADNP Syndrome

> **NCT04388774** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alexander Kolevzon** · enrollment: 10 (actual)

## Conditions studied

- ADNP Syndrome

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT04388774
- **Lead sponsor:** Alexander Kolevzon
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-19
- **Primary completion:** 2021-06-08
- **Final completion:** 2021-06-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04388774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04388774, "Low-Dose Ketamine in Children With ADNP Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04388774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*